INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,433,247 | +669.5% | 203,455 | +892.5% | 0.02% | +466.7% |
| Q2 2023 | $835,990 | -86.2% | 20,500 | -87.4% | 0.00% | -96.7% |
| Q1 2023 | $6,041,616 | +20.1% | 162,104 | +12.4% | 0.09% | -2.2% |
| Q4 2022 | $5,031,975 | +206.3% | 144,224 | +391.2% | 0.09% | +187.5% |
| Q3 2022 | $1,643,000 | -55.2% | 29,361 | -41.9% | 0.03% | -67.3% |
| Q1 2022 | $3,671,000 | +321.0% | 50,521 | +585.1% | 0.10% | +263.0% |
| Q4 2021 | $872,000 | +505.6% | 7,374 | -37.4% | 0.03% | -15.6% |
| Q1 2020 | $144,000 | -69.6% | 11,785 | -63.5% | 0.03% | +6.7% |
| Q4 2019 | $474,000 | +39.8% | 32,297 | +27.6% | 0.03% | +50.0% |
| Q3 2019 | $339,000 | -13.7% | 25,321 | +5.5% | 0.02% | -53.5% |
| Q2 2019 | $393,000 | -35.1% | 24,000 | -32.4% | 0.04% | -56.6% |
| Q1 2019 | $606,000 | – | 35,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |